Literature DB >> 32930344

Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study.

Jaakko S Knuutila1, Pilvi Riihilä, Samu Kurki, Liisa Nissinen, Veli-Matti Kähäri.   

Abstract

Cutaneous squamous cell carcinoma (cSCC) has metastatic potential. The aims of this study were to identify the risk factors for metastasis of primary cSCC and for poor prognosis in metastatic cSCC. Retrospective primary tumour cohorts of metastatic cSCCs (n = 85) and non-metastatic cSCCs (n = 218) were analysed. The mean annual rate of metastasis for primary cSCCs was 2.28%. In 49.4% of patients with metastatic cSCC, metastasis was detected within 6 months of diagnosis of the primary cSCC. There was no prior history of cSCC in 84.7% of metastatic cSCCs. Risk factors for metastasis included Clark's level 5, tumour diameter 20-29.9 mm, age at diagnosis < 50 or 70-79 years, and location on lower lip or forehead. A reduced risk of metastasis correlated with: isosorbide mono-/di-nitrate and/or aspirin use; comorbidity with actinic keratosis or basal cell carcinoma; and actinic keratosis or cSCC in situ as part of, or confirmedly preceding, primary cSCC. Poor prognosis in metastatic cSCC correlated significantly with ≥3 nodal metastases and extranodal extension of metastasis. These results characterize new risk factors for metastatic cSCC.

Entities:  

Keywords:  actinic keratosis; basal cell carcinoma; cancer; cutaneous squamous cell carcinoma in situ; metastasis; skin; keratinocyte carcinoma

Mesh:

Year:  2020        PMID: 32930344      PMCID: PMC9234985          DOI: 10.2340/00015555-3628

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  41 in total

1.  Microstaging of squamous cell carcinomas.

Authors:  H Breuninger; B Black; G Rassner
Journal:  Am J Clin Pathol       Date:  1990-11       Impact factor: 2.493

2.  The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors.

Authors:  Nicholas D L S Brougham; Elizabeth R Dennett; Rujuta Cameron; Swee T Tan
Journal:  J Surg Oncol       Date:  2012-05-16       Impact factor: 3.454

3.  Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.

Authors:  Danielle E Levine; Pritesh S Karia; Chrysalyne D Schmults
Journal:  JAMA Dermatol       Date:  2015-11       Impact factor: 10.282

4.  Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.

Authors:  Nir Hirshoren; Julia Danne; Benjamin John Dixon; Matthew Magarey; Stephen Kleid; Angela Webb; Albert Tiong; June Corry; David Gyorki
Journal:  Head Neck       Date:  2017-02-15       Impact factor: 3.147

Review 5.  Cutaneous Squamous Cell Carcinoma.

Authors:  Vishwas Parekh; John T Seykora
Journal:  Clin Lab Med       Date:  2017-09       Impact factor: 1.935

6.  Prognostic factors for metastasis in squamous cell carcinoma of the skin.

Authors:  Basil S Cherpelis; Christine Marcusen; Pearon G Lang
Journal:  Dermatol Surg       Date:  2002-03       Impact factor: 3.398

Review 7.  Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma.

Authors:  Ben Gurney; Carrie Newlands
Journal:  Br J Oral Maxillofac Surg       Date:  2014-02-20       Impact factor: 1.651

8.  Age is not a predictor of prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck.

Authors:  Joel A Smith; Sohaib Virk; Carsten E Palme; Tsu-Hui Hubert Low; Sydney Ch'ng; Ruta Gupta; Kan Gao; Jonathan Clark
Journal:  ANZ J Surg       Date:  2016-11-07       Impact factor: 1.872

9.  PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.

Authors:  Michael R Migden; Danny Rischin; Chrysalyne D Schmults; Alexander Guminski; Axel Hauschild; Karl D Lewis; Christine H Chung; Leonel Hernandez-Aya; Annette M Lim; Anne Lynn S Chang; Guilherme Rabinowits; Alesha A Thai; Lara A Dunn; Brett G M Hughes; Nikhil I Khushalani; Badri Modi; Dirk Schadendorf; Bo Gao; Frank Seebach; Siyu Li; Jingjin Li; Melissa Mathias; Jocelyn Booth; Kosalai Mohan; Elizabeth Stankevich; Hani M Babiker; Irene Brana; Marta Gil-Martin; Jade Homsi; Melissa L Johnson; Victor Moreno; Jiaxin Niu; Taofeek K Owonikoko; Kyriakos P Papadopoulos; George D Yancopoulos; Israel Lowy; Matthew G Fury
Journal:  N Engl J Med       Date:  2018-06-04       Impact factor: 91.245

10.  Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.

Authors:  Z C Venables; T Nijsten; K F Wong; P Autier; J Broggio; A Deas; C A Harwood; L M Hollestein; S M Langan; E Morgan; C M Proby; J Rashbass; I M Leigh
Journal:  Br J Dermatol       Date:  2019-05-06       Impact factor: 9.302

View more
  8 in total

1.  Retrospective, Registry-based, Cohort Investigation of Clinical Outcomes in Patients with Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in Finland.

Authors:  Samuli Tuominen; Liisa Ukkola-Vuoti; Pilvi Riihilä; Jaakko S Knuutila; Veli-Matti Kähäri; Mariann Lassenius; Tuuli Ranki; Katariina Pousar; Lotta Vassilev; Sauli Vuoti; Kalle Mattila
Journal:  Acta Derm Venereol       Date:  2022-04-08       Impact factor: 3.875

Review 2.  A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review).

Authors:  Benjamin Genenger; Jay R Perry; Bruce Ashford; Marie Ranson
Journal:  Discov Oncol       Date:  2022-06-06

3.  Identification of metastatic primary cutaneous squamous cell carcinoma utilizing artificial intelligence analysis of whole slide images.

Authors:  Jaakko S Knuutila; Pilvi Riihilä; Antti Karlsson; Mikko Tukiainen; Lauri Talve; Liisa Nissinen; Veli-Matti Kähäri
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

4.  Significant Biomarkers Identification Associated with Cutaneous Squamous Cell Carcinoma Progression.

Authors:  Cheng-Gang Qiu; Bin Shen; Xiao-Qi Sun
Journal:  Int J Gen Med       Date:  2022-03-02

5.  Upregulated integrin α11 in the stroma of cutaneous squamous cell carcinoma promotes skin carcinogenesis.

Authors:  Guillermo A Martínez-Nieto; Hanna-Riikka Teppo; Noora Petrelius; Valerio Izzi; Raman Devarajan; Tiina Petäistö; Hengshuo Liu; Kris S Kim; Sanna-Maria Karppinen; Heli Ruotsalainen; Jarkko Koivunen; Joni M Mäki; Gilbert C Walker; Taina Pihlajaniemi; Donald Gullberg; Ritva Heljasvaara
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

6.  Super Enhancer-Regulated LINC00094 (SERLOC) Upregulates the Expression of MMP-1 and MMP-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma.

Authors:  Minna Piipponen; Pilvi Riihilä; Jaakko S Knuutila; Markku Kallajoki; Veli-Matti Kähäri; Liisa Nissinen
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

Review 7.  Matrix metalloproteinases in keratinocyte carcinomas.

Authors:  Pilvi Riihilä; Liisa Nissinen; Veli-Matti Kähäri
Journal:  Exp Dermatol       Date:  2020-09-17       Impact factor: 3.960

8.  Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma.

Authors:  Pegah Rahmati Nezhad; Pilvi Riihilä; Jaakko S Knuutila; Kristina Viiklepp; Sirkku Peltonen; Markku Kallajoki; Seppo Meri; Liisa Nissinen; Veli-Matti Kähäri
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.